Sources | Names Used |
---|---|
GDSC1000 | KIN001-260 |
PharmacoGx | KIN001-260 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZP2 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-06 |
mRNA | ZRANB2 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
mRNA | ZSCAN16 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.009 |
mRNA | ZSCAN2 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.06 |
mRNA | ZSCAN21 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.06 |
mRNA | ZSCAN23 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.07 |
mRNA | ZSCAN4 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.05 |
mRNA | ZSCAN9 | GDSC1000 | pan-cancer | AAC | 0.12 | 6e-05 |
mRNA | ZXDC | GDSC1000 | pan-cancer | AAC | 0.062 | 0.05 |
mRNA | ZYG11B | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |